ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GLENN BOYD MD

Internal Medicine

21,210

$925K

605
552 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

ROBERT MARLER MD

Internal Medicine

21,199

$1.32M

1189
883 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $56

JAMES COBB M.D.

Internal Medicine

21,159

$883K

599
444 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

WILLIAM HUFFMAN M.D.

Internal Medicine

21,154

$1.27M

579
414 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

PALGHAT MOHAN M.D

Internal Medicine

21,061

$1.07M

402
330 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

42%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

OLADAPO FAWIBE MD

Internal Medicine

20,985

$927K

615
318 are 65+

36%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

MCKINLEY BAIN

Internal Medicine

20,866

$1.07M

582
433 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

MARC COAN MD

Internal Medicine

20,852

$1.16M

644
575 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

JAMES KINAHAN MD

Internal Medicine

20,813

$1.14M

866
792 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

ERROL GRAHAM M.D.

Internal Medicine

20,697

$1.09M

654
483 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

HEYWOOD GAY MD

Internal Medicine

20,653

$828K

671
451 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

WILLIAM MCPETERS M.D.

Internal Medicine

20,636

$836K

595
382 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $56

M. POWELL MD

Internal Medicine

20,542

$980K

645
542 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

JAMES SINCLAIR M.D.

Internal Medicine

20,388

$807K

563
305 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

AHMAD JINGO MD

Internal Medicine

20,304

$1.11M

666
312 are 65+

27%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

RAMESH REDDY M.D.

Internal Medicine

20,292

$740K

614
412 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $56

SREEROOP SEN M.D.

Internal Medicine

20,087

$809K

582
483 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

MARK CRUMP MD

Internal Medicine

19,825

$962K

608
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

SANTIAGO GIRALDO MD

Internal Medicine

19,751

$796K

568
425 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

SABIN TOMUS M.D.

Internal Medicine

19,666

$1.16M

531
391 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $56

MICHAEL GEE

Internal Medicine

19,565

$936K

616
536 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

MOHAMMAD AL-SHROOF M.D.

Internal Medicine

19,461

$1.14M

562
277 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

MAXWELL PARROTT M.D.

Internal Medicine

19,407

$1.16M

635
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

LAJOS TOTH MD

Internal Medicine

19,387

$1.19M

1175
867 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $56

VARMA MEKA M.D.

Internal Medicine

19,371

$749K

643
427 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank